BiotechTube
Home/Pipeline/BeiGene Oncology Portfolio

BeiGene Oncology Portfolio

Various solid tumors

Phase 2/3Active

Key Facts

Indication
Various solid tumors
Phase
Phase 2/3
Status
Active
Company
EVA Pharma

About EVA Pharma

Egypt’s top pharma firm, EVA Pharma, combines large‑scale manufacturing with R&D to deliver diverse medicines across Africa.

View full company profile

Therapeutic Areas

OncologyNeuroscienceRespiratoryCardiometabolic MedicineAnti‑infectivesOphthalmologyBone HealthPain ManagementHepatologySlimming and Well‑beingSexual and Reproductive Health

Other Various solid tumors Drugs

DrugCompanyPhase
NUC-8232NuCanaPhase 1
TCR Library ProgramMedigeneDiscovery
Guardant Infinity Biomarker DiscoveryGuardant HealthDevelopment/Commercial
Cytotoxic Oncology GenericMSN LaboratoriesPre‑clinical
APCEDEN®APAC BiotechApproved
Solid Tumor ProfilingDiatech PharmacogeneticsCommercial
BAVENCIO (avelumab)EMD SeronoApproved
FoundationOne®CDx Indication ExpansionFoundation MedicineApproved/Commercial
FoundationOne®Liquid CDx Indication ExpansionFoundation MedicineApproved/Commercial
177Lu‑BetaBart (RV‑01)AtomVie Global RadiopharmaPhase 1/2a
Bevacizumab BiosimilarBio Usawa BiotechnologyPreclinical
PRIMO‑TB161‑001Primo BiotechnologyPreclinical